Merck agrees to build bioprocessing production plant in South Korea

Xin Weisheng

Home > News > INDUSTRY NEWS >

03 May 2023
Merck agrees to build bioprocessing production plant in South Korea

Merck’s Life Science business has entered into a non-binding memorandum of understanding (MOU) with the South Korean Ministry of Trade, Industry and Energy (MOTIE), and Daejeon City to establish a new bioprocessing production facility, to be known as the Asia Pacific BioProcessing Production Centre.


It will be situated in South Korea’s Daejeon City and will help biotech and pharmaceutical clients in the region with commercial production.


Merck also plans to collaborate with the Daejeon government to offer help to biotech firms in the Daedeok research complex in Daejeon, and to forge partnerships in bio-research with major Korean universities.


Merck executive board member and life science CEO Matthias Heinzel stated: “South Korea is an emerging global leader in the biotech industry, and this MoU demonstrates Merck’s commitment to the region by working closely with the government to better support our customers.


“The proposed facility would play a vital role in fulfilling demand in the Asia Pacific region while representing an important hub for further biopharma industry development in South Korea.”


Merck is a science and technology firm with operations across life science, healthcare and the electronics industries.


Daejeon mayor Jang Woo Lee stated: “Daejeon is the birthplace of the Korean biotech industry. Today it’s where companies, big and small, are intensely focused on technological innovation and talent development to bring new and novel therapies to market”.


“Together with Merck, this planned investment cooperation will help support Daejeon’s growth to become a world-class biotech hub.”


(Source: Pharmaceutical Technology)

  • wechat
Recent Posts
  • Biosphere zaps germs with UV light to make biomanufacturing cheaper
    09 Jan 2025
    Biosphere zaps germs with UV light to make biomanufacturing cheaper
    Find out more
  • China's API Dominance Reshapes Global Pharmaceutical Supply Chains
    04 Dec 2024
    China's API Dominance Reshapes Global Pharmaceutical Supply Chains
    Find out more
  • From mundane to marvelous: The current and future uses of AI
    13 Nov 2024
    From mundane to marvelous: The current and future uses of AI
    Find out more

WANT TO KNOW MORE ABOUT HOW OUR

SOLUTIONS CAN HELP YOU?

Cookies
Our site uses cookies. We’d also like to set optional cookies to give you the best experience and porvide you relevant advertising. You can choose to manage your preferences or accept all cookies. You can also read our Privacy Policy and Cookie Policy for more information.